These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
229 related articles for article (PubMed ID: 2039203)
1. Acquired resistance of Nocardia brasiliensis to clavulanic acid related to a change in beta-lactamase following therapy with amoxicillin-clavulanic acid. Steingrube VA; Wallace RJ; Brown BA; Pang Y; Zeluff B; Steele LC; Zhang Y Antimicrob Agents Chemother; 1991 Mar; 35(3):524-8. PubMed ID: 2039203 [TBL] [Abstract][Full Text] [Related]
2. Partial characterization of Nocardia farcinica beta-lactamases. Steingrube VA; Wallace RJ; Brown BA; Zhang Y; Steele LC; Young G; Nash DR Antimicrob Agents Chemother; 1993 Sep; 37(9):1850-5. PubMed ID: 8239595 [TBL] [Abstract][Full Text] [Related]
3. Beta-lactam resistance in Nocardia brasiliensis is mediated by beta-lactamase and reversed in the presence of clavulanic acid. Wallace RJ; Nash DR; Johnson WK; Steele LC; Steingrube VA J Infect Dis; 1987 Dec; 156(6):959-66. PubMed ID: 3500241 [TBL] [Abstract][Full Text] [Related]
4. Role of Bacteroides bivius beta-lactamase in beta-lactam susceptibility. Lacroix JM; Lamothe F; Malouin F Antimicrob Agents Chemother; 1984 Nov; 26(5):694-8. PubMed ID: 6335019 [TBL] [Abstract][Full Text] [Related]
5. Increased beta-lactamase activity in Branhamella catarrhalis after exposure to amoxicillin and clavulanic acid. Bedenić B; Zagar Z J Chemother; 1994 Dec; 6(6):383-7. PubMed ID: 7699424 [TBL] [Abstract][Full Text] [Related]
6. Inhibition Activity of Avibactam against Nocardia farcinica β-Lactamase FAR Lebeaux D; Ourghanlian C; Dorchène D; Soroka D; Edoo Z; Compain F; Arthur M Antimicrob Agents Chemother; 2020 Jan; 64(2):. PubMed ID: 31712200 [No Abstract] [Full Text] [Related]
7. In-vitro susceptibility of Nocardia asteroides to 21 beta-lactam antibiotics, in combination with three beta-lactamase inhibitors, and its relationship to the beta-lactamase content. Kitzis MD; Gutmann L; Acar JF J Antimicrob Chemother; 1985 Jan; 15(1):23-30. PubMed ID: 3882654 [TBL] [Abstract][Full Text] [Related]
8. Effect of hyperproduction of TEM-1 beta-lactamase on in vitro susceptibility of Escherichia coli to beta-lactam antibiotics. Wu PJ; Shannon K; Phillips I Antimicrob Agents Chemother; 1994 Mar; 38(3):494-8. PubMed ID: 8203843 [TBL] [Abstract][Full Text] [Related]
9. Back mutations to the TEM-1 beta-lactamase from TRC-1 lead to restored sensitivity to clavulanic acid. Thomson CJ; Amyes SG J Med Microbiol; 1995 Jun; 42(6):429-32. PubMed ID: 7791208 [TBL] [Abstract][Full Text] [Related]
10. Susceptibilities of beta-lactamase-positive and -negative strains of Campylobacter coli to beta-lactam agents. Lachance N; Gaudreau C; Lamothe F; Turgeon F Antimicrob Agents Chemother; 1993 May; 37(5):1174-6. PubMed ID: 8390812 [TBL] [Abstract][Full Text] [Related]
11. Incidence and mechanisms of resistance to the combination of amoxicillin and clavulanic acid in Escherichia coli. Stapleton P; Wu PJ; King A; Shannon K; French G; Phillips I Antimicrob Agents Chemother; 1995 Nov; 39(11):2478-83. PubMed ID: 8585729 [TBL] [Abstract][Full Text] [Related]
12. In vitro activities of the beta-lactamase inhibitors clavulanic acid, sulbactam, and tazobactam alone or in combination with beta-lactams against epidemiologically characterized multidrug-resistant Acinetobacter baumannii strains. Higgins PG; Wisplinghoff H; Stefanik D; Seifert H Antimicrob Agents Chemother; 2004 May; 48(5):1586-92. PubMed ID: 15105109 [TBL] [Abstract][Full Text] [Related]
13. Antibacterial activities of amoxicillin alone and in combination with clavulanic acid correlated with beta-lactamase production. Hsu LY; Chang SC; Luh KT; Hsieh WC Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1991 Aug; 24(3):272-80. PubMed ID: 1818798 [TBL] [Abstract][Full Text] [Related]
15. Role of the beta-lactamase of Campylobacter jejuni in resistance to beta-lactam agents. Lachance N; Gaudreau C; Lamothe F; Larivière LA Antimicrob Agents Chemother; 1991 May; 35(5):813-8. PubMed ID: 1854162 [TBL] [Abstract][Full Text] [Related]
16. [In vitro susceptibility of pathogenic Nocardia to beta-lactam antibiotics, especially imipenem, a carbapenem antibiotic]. Yazawa K; Mikami Y; Otozai K; Uno J; Arai T Jpn J Antibiot; 1989 Nov; 42(11):2354-62. PubMed ID: 2695658 [TBL] [Abstract][Full Text] [Related]
17. Selection of variants of the TEM-1 beta-lactamase, encoded by a plasmid of clinical origin, with increased resistance to beta-lactamase inhibitors. Thomson CJ; Amyes SG J Antimicrob Chemother; 1993 May; 31(5):655-64. PubMed ID: 8392995 [TBL] [Abstract][Full Text] [Related]
18. Beta-lactamase inhibitors: another approach to overcoming antimicrobial resistance. Parker RH; Eggleston M Infect Control; 1987 Jan; 8(1):36-40. PubMed ID: 3028975 [TBL] [Abstract][Full Text] [Related]
19. Antimicrobial susceptibilities of Campylobacter jejuni and Campylobacter coli to 12 beta-lactam agents and combinations with beta-lactamase inhibitors. Tajada P; Gomez-Graces JL; Alós JI; Balas D; Cogollos R Antimicrob Agents Chemother; 1996 Aug; 40(8):1924-5. PubMed ID: 8843305 [TBL] [Abstract][Full Text] [Related]
20. Activity of beta-lactamase inhibitor combinations on Escherichia coli isolates exhibiting various patterns of resistance to beta-lactam agents. Vanjak D; Muller-Serieys C; Picard B; Bergogne-Berezin E; Lambert-Zechovsky N Eur J Clin Microbiol Infect Dis; 1995 Nov; 14(11):972-8. PubMed ID: 8654448 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]